Fingolimod (Gilenya) not effective in primary progressive MS

Fingolimod (Gilenya) was no better than placebo at reducing measures of progression in people with primary progressive MS according to information announced today.
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news